Andrea Bianchi-Sartore

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 192 publications

Predictive biomarkers for cetuximab-based rechallenge therapy in metastatic colorectal cancer: a pooled analysis of the CAVE and CAVE-2 GOIM studies.

Predictive biomarkers for cetuximab-based rechallenge therapy in metastatic colorectal cancer: a pooled analysis of the CAVE and CAVE-2 GOIM studies.

Journal: ESMO gastrointestinal oncology

Published: August 28, 2026

Absence of co-occurrence between HER2 amplification and dMMR/MSI in a large multicentric colorectal cancer cohort.

Absence of co-occurrence between HER2 amplification and dMMR/MSI in a large multicentric colorectal cancer cohort.

Journal: Scientific reports

Published: March 12, 2026

Author Correction: The genomic landscape of response to EGFR blockade in colorectal cancer.

Author Correction: The genomic landscape of response to EGFR blockade in colorectal cancer.

Journal: Nature

Published: February 16, 2026

Patient-Reported Experience Measures (PREMs) in patients with metastatic colorectal cancer undergoing treatment supported by feedback auditing: the EPIC study.

Patient-Reported Experience Measures (PREMs) in patients with metastatic colorectal cancer undergoing treatment supported by feedback auditing: the EPIC study.

Journal: ESMO gastrointestinal oncology

Published: February 06, 2026

Germline genomic profiling of patients with early-onset colorectal cancer.

Germline genomic profiling of patients with early-onset colorectal cancer.

Journal: ESMO gastrointestinal oncology

Published: February 06, 2026

Locally advanced rectal cancer: what patients and practitioners should know about non-operative management.

Locally advanced rectal cancer: what patients and practitioners should know about non-operative management.

Journal: EClinicalMedicine

Published: December 22, 2025

Diagnosis and treatment of human epidermal growth factor receptor 2-positive metastatic colorectal cancer: a systematic literature review.

Diagnosis and treatment of human epidermal growth factor receptor 2-positive metastatic colorectal cancer: a systematic literature review.

Journal: Cancer treatment reviews

Published: November 25, 2025

Degrees of H2AX phosphorylation correlate with unique features of the intratumoral immune microenvironment in colorectal carcinomas.

Degrees of H2AX phosphorylation correlate with unique features of the intratumoral immune microenvironment in colorectal carcinomas.

Journal: The oncologist

Published: November 05, 2025

Cetuximab rechallenge in molecularly selected metastatic colorectal cancer: the randomized CAVE-2 GOIM trial.

Cetuximab rechallenge in molecularly selected metastatic colorectal cancer: the randomized CAVE-2 GOIM trial.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: November 04, 2025

Liquid biopsy in Oncology: Results of a Delphi consensus study endorsed by the AIOM-SIAPEC/IAP-SIBioC-SIF Italian scientific societies.

Liquid biopsy in Oncology: Results of a Delphi consensus study endorsed by the AIOM-SIAPEC/IAP-SIBioC-SIF Italian scientific societies.

Journal: The journal of liquid biopsy

Published: October 08, 2025

WEE1 kinase inhibition to overcome acquired resistance to targeted therapies in colorectal cancer.

WEE1 kinase inhibition to overcome acquired resistance to targeted therapies in colorectal cancer.

Journal: EMBO molecular medicine

Published: September 30, 2025

Targeting HER2 in Metastatic Colorectal Cancer: Current Therapies, Biomarker Refinement, and Emerging Strategies.

Targeting HER2 in Metastatic Colorectal Cancer: Current Therapies, Biomarker Refinement, and Emerging Strategies.

Journal: Drugs

Published: September 08, 2025

Showing 1-12 of 192

Last Updated: 09/26/2026